![Taro Pharmaceutical Industries Ltd. Logo](/news-release/logo/214827/0/214827.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A32&size=2)
Taro Announces Approvals of ANDAs for Betamethasone Dipropionate Ointment (Augmented) and Ciprofloxacin Tablets
October 13, 2004 07:00 ET
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., Oct. 13, 2004 (PRIMEZONE) -- Taro Pharmaceutical Industries Ltd. ("Taro") (Nasdaq:TARO) reported today that Taro Pharmaceuticals U.S.A., Inc. ("Taro USA"), its U.S. affiliate, has...
![Taro Pharmaceutical Industries Ltd. Logo](/news-release/logo/214827/0/214827.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A32&size=2)
Taro Receives FDA Approval For Loratadine Syrup, 5 mg / 5 ml ANDA
August 20, 2004 15:49 ET
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., Aug. 20, 2004 (PRIMEZONE) -- Taro Pharmaceutical Industries Ltd. (Nasdaq:TARO) ("Taro") reported today that it has received approval from the U.S. Food and Drug Administration...
![Taro Pharmaceutical Industries Ltd. Logo](/news-release/logo/214827/0/214827.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A32&size=2)
Taro Receives Final Approval For Fluconazole Tablets ANDA
July 29, 2004 14:07 ET
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., July 29, 2004 (PRIMEZONE) -- Taro Pharmaceutical Industries Ltd. (Nasdaq:TARO) reported today that its U.S. affiliate has received final approval from the U.S. Food and Drug...
![Taro Pharmaceutical Industries Ltd. Logo](/news-release/logo/214827/0/214827.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A32&size=2)
Taro to Report 2nd Quarter 2004 Results and Conduct Conference Call On July 29, 2004
July 27, 2004 20:03 ET
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., July 27, 2004 (PRIMEZONE) -- Taro Pharmaceutical Industries Ltd. (Nasdaq:TARO) intends to report financial results for the second quarter of 2004 prior to the Nasdaq market opening...
![Taro Pharmaceutical Industries Ltd. Logo](/news-release/logo/214827/0/214827.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A32&size=2)
Taro Receives FDA Approval For Ammonium Lactate Lotion, 12% ANDA
June 01, 2004 09:39 ET
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., June 1, 2004 (PRIMEZONE) -- Taro Pharmaceutical Industries Ltd. (Nasdaq:TARO) reported today that its U.S. affiliate has received approval from the U.S. Food and Drug Administration...
![Taro Pharmaceutical Industries Ltd. Logo](/news-release/logo/214827/0/214827.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A32&size=2)
Taro to Report 4th Quarter and Full Year 2003 Results and Conduct Conference Call on February 17, 2004
February 13, 2004 10:13 ET
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., Feb. 13, 2004 (PRIMEZONE) -- Taro Pharmaceutical Industries Ltd. (Nasdaq:TARO) intends to report financial results for the fourth quarter and full year 2003 prior to the Nasdaq...
![Taro Pharmaceutical Industries Ltd. Logo](/news-release/logo/214827/0/214827.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A32&size=2)
Taro Expands U.S. Distribution Capacity with Purchase of New Jersey Facility
January 08, 2004 07:00 ET
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., Jan. 8, 2004 (PRIMEZONE) -- Taro Pharmaceutical Industries Ltd. (Nasdaq:TARO) today announced that its U.S. affiliate has expanded its distribution capacity with the purchase of a...
![Taro Pharmaceutical Industries Ltd. Logo](/news-release/logo/214827/0/214827.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A32&size=2)
Taro Completes $50 Million Non-Convertible Debt Offering
December 01, 2003 07:00 ET
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., Dec. 01, 2003 (PRIMEZONE) -- Taro Pharmaceutical Industries Ltd. (Nasdaq:TARO) today announced the completion of a $50 million offering of long-term, non-convertible debt to...
![Taro Pharmaceutical Industries Ltd. Logo](/news-release/logo/214827/0/214827.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A32&size=2)
Taro Announces Filing of ANDA for Gabapentin Capsules, 100 mg, 300 mg, 400 mg
November 17, 2003 13:26 ET
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., Nov. 17, 2003 (PRIMEZONE) -- Taro Pharmaceutical Industries Ltd. (Nasdaq:TARO) reported today that its U.S. affiliate has filed an Abbreviated New Drug Application ("ANDA") with the...
![Taro Pharmaceutical Industries Ltd. Logo](/news-release/logo/214827/0/214827.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A32&size=2)
Taro Added to Nasdaq Biotechnology Index
November 14, 2003 07:00 ET
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., Nov. 14, 2003 (PRIMEZONE)-- Taro Pharmaceutical Industries Ltd. (Nasdaq:TARO) today announced that it has been selected for inclusion in the Nasdaq Biotechnology Index (NBI). The...